"gemtuzumab ozogamicin" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-tu-",
        "3": "-zu-",
        "4": "-mab"
      },
      "expansion": "-tu- + -zu- + -mab",
      "name": "compound"
    }
  ],
  "etymology_text": "-tu- + -zu- + -mab",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "gemtuzumab ozogamicin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -tu-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -zu-",
          "parents": [],
          "source": "w"
        }
      ],
      "glosses": [
        "an monoclonal antibody targeting CD33, having a cytotoxic calicheamicin-class agent attached, which was used to treat acute myelogenous leukemia until withdrawn out of lethal toxicity"
      ],
      "id": "en-gemtuzumab_ozogamicin-en-noun-8BngOnmV",
      "links": [
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "CD33",
          "CD33"
        ],
        [
          "cytotoxic",
          "cytotoxic"
        ],
        [
          "calicheamicin",
          "calicheamicin"
        ],
        [
          "acute myelogenous leukemia",
          "acute myelogenous leukemia"
        ],
        [
          "toxicity",
          "toxicity"
        ]
      ],
      "synonyms": [
        {
          "sense": "trade mark",
          "word": "Mylotarg"
        }
      ],
      "tags": [
        "uncountable"
      ],
      "wikipedia": [
        "gemtuzumab ozogamicin"
      ]
    }
  ],
  "word": "gemtuzumab ozogamicin"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-tu-",
        "3": "-zu-",
        "4": "-mab"
      },
      "expansion": "-tu- + -zu- + -mab",
      "name": "compound"
    }
  ],
  "etymology_text": "-tu- + -zu- + -mab",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "gemtuzumab ozogamicin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English compound terms",
        "English entries with incorrect language header",
        "English lemmas",
        "English multiword terms",
        "English nouns",
        "English terms interfixed with -tu-",
        "English terms interfixed with -zu-",
        "English uncountable nouns"
      ],
      "glosses": [
        "an monoclonal antibody targeting CD33, having a cytotoxic calicheamicin-class agent attached, which was used to treat acute myelogenous leukemia until withdrawn out of lethal toxicity"
      ],
      "links": [
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "CD33",
          "CD33"
        ],
        [
          "cytotoxic",
          "cytotoxic"
        ],
        [
          "calicheamicin",
          "calicheamicin"
        ],
        [
          "acute myelogenous leukemia",
          "acute myelogenous leukemia"
        ],
        [
          "toxicity",
          "toxicity"
        ]
      ],
      "tags": [
        "uncountable"
      ],
      "wikipedia": [
        "gemtuzumab ozogamicin"
      ]
    }
  ],
  "synonyms": [
    {
      "sense": "trade mark",
      "word": "Mylotarg"
    }
  ],
  "word": "gemtuzumab ozogamicin"
}